Novo Holdings A/S Long-Term Concentrated

Location: Hellerup, Denmark

CIK: 0001388325 · Show all filings

Period: Q4 2016 (← Previous) (Next →)

Filing Date: Feb 14, 2017

Total Value: $1.05B (99.4% shares, 0.6% debt)

Holdings (22)

INGN INOGEN INC 22.7%
Value $238M Shares 3,549,320 Share Price $67.17 * Est. Cost/Share $17.78 Unrealized @ Report Date +246.8%
VTI VANGUARD INDEX FDS 17.8%
Value $187M Shares 1,623,100 Share Price $115.32 Est. Cost/Share $57.39 Unrealized @ Report Date —
— COLUCID PHARMACEUTICALS INC 10.9%
Value $115M Shares 3,156,563 Share Price $36.40 Est. Cost/Share $9.83 Unrealized @ Report Date —
VGK VANGUARD INTL EQUITY INDEX F 9.6%
Value $101M Shares 2,101,000 Share Price $47.94 Est. Cost/Share $45.01 Unrealized @ Report Date —
— REATA PHARMACEUTICALS INC 7.0%
Value $73.52M Shares 3,367,763 Share Price $21.83 Est. Cost/Share $19.75 Unrealized @ Report Date —
IRTC IRHYTHM TECHNOLOGIES INC 5.8%
Value $60.73M Shares 2,024,448 Share Price $30.00 * Est. Cost/Share $26.94 Unrealized @ Report Date 0.0%
CRVS CORVUS PHARMACEUTICALS INC 4.4%
Value $46.1M Shares 3,224,046 Share Price $14.30 * Est. Cost/Share $14.33 Unrealized @ Report Date +6.1%
— ACCELERON PHARMA INC 3.0%
Value $31.65M Shares 1,240,173 Share Price $25.52 Est. Cost/Share $27.95 Unrealized @ Report Date —
— RA PHARMACEUTICALS INC 2.9%
Value $30.86M Shares 2,031,562 Share Price $15.19 Est. Cost/Share $15.19 Unrealized @ Report Date —
— MERUS N V 2.8%
Value $29.77M Shares 1,410,417 Share Price $21.11 Est. Cost/Share $7.99 Unrealized @ Report Date —
— SPECTRANETICS CORP 2.8%
Value $28.89M Shares 1,179,122 Share Price $24.50 Est. Cost/Share $18.19 Unrealized @ Report Date —
— FLEXION THERAPEUTICS INC 2.5%
Value $26.59M Shares 1,397,718 Share Price $19.02 Est. Cost/Share $16.32 Unrealized @ Report Date —
KALV KALVISTA PHARMACEUTICALS INC 2.0%
Value $20.52M Shares 2,901,927 Share Price $7.07 * Est. Cost/Share $7.37 Unrealized @ Report Date 0.0%
— APOLLO ENDOSURGERY INC 1.7%
Value $17.72M Shares 1,456,972 Share Price $12.16 Est. Cost/Share $12.16 Unrealized @ Report Date —
— NABRIVA THERAPEUTICS AG 1.3%
Value $13.87M Shares 2,326,544 Share Price $5.96 Est. Cost/Share $7.44 Unrealized @ Report Date —
— INVUITY INC 0.7%
Value $7.581M Shares 1,318,448 Share Price $5.75 Est. Cost/Share $9.58 Unrealized @ Report Date —
— DERMIRA INC 0.6%
Value $6.568M Shares 216,562 Share Price $30.33 Est. Cost/Share $30.33 Unrealized @ Report Date —
— WRIGHT MED GROUP N V 0.6%
Value $6.101M Shares 4,622,032 Share Price $1.32 Est. Cost/Share $1.25 Unrealized @ Report Date —
CRSP CRISPR THERAPEUTICS AG 0.4%
Value $4.524M Shares 223,317 Share Price $20.26 * Est. Cost/Share $18.69 Unrealized @ Report Date 0.0%
— HTG MOLECULAR DIAGNOSTICS INC 0.3%
Value $2.868M Shares 1,280,185 Share Price $2.24 Est. Cost/Share $11.15 Unrealized @ Report Date —
XENE XENON PHARMACEUTICALS INC 0.1%
Value $982K Shares 127,563 Share Price $7.70 * Est. Cost/Share $14.68 Unrealized @ Report Date -45.3%
OPK OPKO HEALTH INC 0.0%
Value $2,000 Shares 259 Share Price $7.72 * Est. Cost/Share $9.96 Unrealized @ Report Date +3.9%